Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals

<i>Background and Objectives</i>: Pregnancy and delivery in patients with congenital heart disease (CHD) and pulmonary arterial hypertension (PAH) carry a very high risk for maternal and foetal complications and are contraindicated according to the guidelines. In the last decades, when a...

Full description

Bibliographic Details
Main Authors: Virginija Rudienė, Lina Kaplerienė, Dovilė Jančauskaitė, Emilija Meškėnė, Eglė Palevičiūtė, Monika Laukytė-Slėnienė, Diana Gasiūnaitė, Diana Ramašauskaitė, Elena Jurevičienė, Lina Gumbienė
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Medicina
Subjects:
Online Access:https://www.mdpi.com/1648-9144/58/4/476
_version_ 1797445037515079680
author Virginija Rudienė
Lina Kaplerienė
Dovilė Jančauskaitė
Emilija Meškėnė
Eglė Palevičiūtė
Monika Laukytė-Slėnienė
Diana Gasiūnaitė
Diana Ramašauskaitė
Elena Jurevičienė
Lina Gumbienė
author_facet Virginija Rudienė
Lina Kaplerienė
Dovilė Jančauskaitė
Emilija Meškėnė
Eglė Palevičiūtė
Monika Laukytė-Slėnienė
Diana Gasiūnaitė
Diana Ramašauskaitė
Elena Jurevičienė
Lina Gumbienė
author_sort Virginija Rudienė
collection DOAJ
description <i>Background and Objectives</i>: Pregnancy and delivery in patients with congenital heart disease (CHD) and pulmonary arterial hypertension (PAH) carry a very high risk for maternal and foetal complications and are contraindicated according to the guidelines. In the last decades, when an available modern PAH-targeted medication therapy and a new management concept improved patients’ well-being and survival, some PAH-CHD females decided to conceive. Of note, despite advanced treatment and modern healthcare system possibilities, dealing with pregnancy in a diverse PAH-CHD population is still challenging. The study aimed to share our experience with PAH-CHD pregnancies and discuss the risk assessment and current management of these patients with the combination of two rare diseases. <i>Materials and Methods</i>: The retrospective search of pulmonary hypertension and adult CHD registries in our hospital was performed, selecting all patients with CHD and PAH who conceived pregnancy from 2013 to 2021. Baseline demographic, clinical, and functional characteristics and clinical outcomes were collected. <i>Results</i>: Thirteen pregnancies in eight patients with PAH-CHD resulted in seven live births, three miscarriages, and three terminations. Five women were diagnosed with Eisenmenger syndrome (ES) and three with residual PAH after CHD repair. Before pregnancy, half of them were in WHO functional class III. Seven (87.5%) patients received targeted PAH treatment with sildenafil during pregnancy. In addition, the two most severe cases were administered with iloprost during peripartum. Three ES patients delivered preterm by Caesarean section under general anaesthesia. No neonatal mortality was reported. Maternal complications were observed in half of our cases. One patient died 12 days after the delivery in another hospital due to deterioration of heart failure. <i>Conclusions</i>: On the basis of our clinical experience, we conclude that pregnancy and delivery carry a high risk for maternal complications and should be avoided in women with PAH-CHD. The individualised approach of multidisciplinary care and appropriate monitoring are mandatory in reducing the risk of adverse outcomes.
first_indexed 2024-03-09T13:20:01Z
format Article
id doaj.art-06290307d2674ac89fcf3568a4d72f12
institution Directory Open Access Journal
issn 1010-660X
1648-9144
language English
last_indexed 2024-03-09T13:20:01Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Medicina
spelling doaj.art-06290307d2674ac89fcf3568a4d72f122023-11-30T21:30:10ZengMDPI AGMedicina1010-660X1648-91442022-03-0158447610.3390/medicina58040476Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare ProfessionalsVirginija Rudienė0Lina Kaplerienė1Dovilė Jančauskaitė2Emilija Meškėnė3Eglė Palevičiūtė4Monika Laukytė-Slėnienė5Diana Gasiūnaitė6Diana Ramašauskaitė7Elena Jurevičienė8Lina Gumbienė9Clinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-08661 Vilnius, LithuaniaClinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-08661 Vilnius, LithuaniaClinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-08661 Vilnius, LithuaniaClinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-08661 Vilnius, LithuaniaClinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-08661 Vilnius, LithuaniaClinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-08661 Vilnius, LithuaniaCentre of Anaesthesiology, Intensive Therapy and Pain Management, Faculty of Medicine, Vilnius University, LT-08661 Vilnius, LithuaniaFaculty of Medicine, Vilnius University, LT-03101 Vilnius, LithuaniaFaculty of Medicine, Vilnius University, LT-03101 Vilnius, LithuaniaClinic of Cardiac and Vascular Diseases, Faculty of Medicine, Institute of Clinical Medicine, Vilnius University, LT-08661 Vilnius, Lithuania<i>Background and Objectives</i>: Pregnancy and delivery in patients with congenital heart disease (CHD) and pulmonary arterial hypertension (PAH) carry a very high risk for maternal and foetal complications and are contraindicated according to the guidelines. In the last decades, when an available modern PAH-targeted medication therapy and a new management concept improved patients’ well-being and survival, some PAH-CHD females decided to conceive. Of note, despite advanced treatment and modern healthcare system possibilities, dealing with pregnancy in a diverse PAH-CHD population is still challenging. The study aimed to share our experience with PAH-CHD pregnancies and discuss the risk assessment and current management of these patients with the combination of two rare diseases. <i>Materials and Methods</i>: The retrospective search of pulmonary hypertension and adult CHD registries in our hospital was performed, selecting all patients with CHD and PAH who conceived pregnancy from 2013 to 2021. Baseline demographic, clinical, and functional characteristics and clinical outcomes were collected. <i>Results</i>: Thirteen pregnancies in eight patients with PAH-CHD resulted in seven live births, three miscarriages, and three terminations. Five women were diagnosed with Eisenmenger syndrome (ES) and three with residual PAH after CHD repair. Before pregnancy, half of them were in WHO functional class III. Seven (87.5%) patients received targeted PAH treatment with sildenafil during pregnancy. In addition, the two most severe cases were administered with iloprost during peripartum. Three ES patients delivered preterm by Caesarean section under general anaesthesia. No neonatal mortality was reported. Maternal complications were observed in half of our cases. One patient died 12 days after the delivery in another hospital due to deterioration of heart failure. <i>Conclusions</i>: On the basis of our clinical experience, we conclude that pregnancy and delivery carry a high risk for maternal complications and should be avoided in women with PAH-CHD. The individualised approach of multidisciplinary care and appropriate monitoring are mandatory in reducing the risk of adverse outcomes.https://www.mdpi.com/1648-9144/58/4/476pulmonary arterial hypertensioncongenital heart diseasepregnancyrare diseasesmultidisciplinary team
spellingShingle Virginija Rudienė
Lina Kaplerienė
Dovilė Jančauskaitė
Emilija Meškėnė
Eglė Palevičiūtė
Monika Laukytė-Slėnienė
Diana Gasiūnaitė
Diana Ramašauskaitė
Elena Jurevičienė
Lina Gumbienė
Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals
Medicina
pulmonary arterial hypertension
congenital heart disease
pregnancy
rare diseases
multidisciplinary team
title Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals
title_full Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals
title_fullStr Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals
title_full_unstemmed Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals
title_short Pregnancy in Congenital Heart Disease, Complicated by Pulmonary Arterial Hypertension—A Challenging Issue for the Pregnant Woman, the Foetus, and Healthcare Professionals
title_sort pregnancy in congenital heart disease complicated by pulmonary arterial hypertension a challenging issue for the pregnant woman the foetus and healthcare professionals
topic pulmonary arterial hypertension
congenital heart disease
pregnancy
rare diseases
multidisciplinary team
url https://www.mdpi.com/1648-9144/58/4/476
work_keys_str_mv AT virginijarudiene pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT linakapleriene pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT dovilejancauskaite pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT emilijameskene pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT eglepaleviciute pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT monikalaukytesleniene pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT dianagasiunaite pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT dianaramasauskaite pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT elenajureviciene pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals
AT linagumbiene pregnancyincongenitalheartdiseasecomplicatedbypulmonaryarterialhypertensionachallengingissueforthepregnantwomanthefoetusandhealthcareprofessionals